CDI
Conditions
Brief summary
To decrease CDI incidence by implementing an electronic health record-integrated CDI-risk classification tool for Clostridioides difficile infection (CDI) to focus a bundle of antimicrobial stewardship (AMS) CDI prevention recommendations on high-risk patients.
Detailed description
This study aims to use a pre/post implementation design to evaluate the use of a novel risk classification tool to improve existing methods of identifying patients eligible for routine antimicrobial stewardship (AMS) care processes targeting reduction of Clostridioides difficile infection (CDI). Antimicrobial stewardship is an established, evidence-based quality improvement program that is required by The Joint Commission and a condition of participation by the Centers for Medicare and Medicaid. AMS processes of care are evidence based, supported by published research demonstrating outcomes benefits, are recommended by national guidelines and are not investigational. Treatment decisions remain at the discretion of clinicians and patients
Interventions
OTHERCDI-risk Classification Tool
This tool will focus a bundle of antimicrobial stewardship (AMS) CDI prevention recommendations on high-risk patients.
Sponsors
Intermountain Health Care, Inc.
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* adult acute care patients identified as high-CDI risk by the CDI risk classification tool. This sub-group represents approximately 6% of all acute care admissions
Exclusion criteria
* Behavioral health units * Inpatient rehabilitation units * Labor and Delivery units * Same day surgery and observation units
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Per-Admission Rate | 30 days after discharge | per-admission rate of hospital-associated CDI, defined as: positive toxin B by enzyme-linked immunoassay or polymerase chain reaction test at least 72 hours after admission |
Secondary
| Measure | Time frame |
|---|---|
| Total Antibiotic Usage | through study completion, an average of 1 year |
| High-Risk Antibiotic Usage | through study completion, an average of 1 year |
| Proton Pump Inhibitor Therapy Administered | through study completion, an average of 1 year |
| Total Variable Cost per Admission | through study completion, an average of 1 year |
| Hospital Length of Stay | through study completion, an average of 1 year |
Countries
United States
Outcome results
None listed